Try our Advanced Search for more refined results
Searching dockets in Weisman Kennedy x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
P.I.: Other | Tennessee Middle
Reply to Response to Motion
REPLY to Response to re 240 MOTION to Exclude Kristin Weivoda as an Expert Witness Pursuant to Federal Rules of Evidence 702 and 703 filed by CSX Transportation, Inc.. (Attachments: # 1 Exhibit 1-Kristin Weivoda Depo Excerpts, # 2 Exhibit 2-Corey Oakley depo excerpts, # 3 Exhibit 3-Bobby Brown depo excerpts, # 4 Exhibit 4- Chief Gillespie nixle alerts, # 5 Exhibit 5- Social media pages, # 6 Exhibit 6-Gillespi Depo Excerpts)(Reifers, Stephanie)
P.I.: Other | Ohio Northern
Order
Motion by Third Party Payor Plaintiffs' for (1) Final Approval of Class Action Settlement with Allergan, Janssen, Teva, and Settling Pharmacies; and (2) Award of Attorneys' Fees and Expenses and Settlement Class Representative Service Awards filed by Plaintiff Plaintiffs Liaison Counsel. (Attachments: # 1 Joint Declaration of Elizabeth J. Cabraser and Paul J. Geller, # 2 Exhibit A - Prof. William B. Rubenstein Declaration, # 3 Proposed Order - Allergan, # 4 Proposed Order - Janssen, # 5 Proposed Order - Teva, # 6 Proposed Order - Settling Pharmacies)(Weinberger, Peter)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.